Initial manifestations and risk factors for calcinosis in juvenile dermatomyositis: A retrospective multicenter study
Authors:
Open Access
- 21 June 2023
- journal article
- research article
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 10 (3) , 298-305
Abstract
OBJECTIVE: This study aimed to look for the initial manifestations of juvenile dermatomyositis (JDM), give follow-up results, and search for risk factors for the development of calcinosis. METHODS: The files of children with JDM diagnosed between 2005 and 2020 were reviewed retrospectively. RESULTS: The study included 48 children, 33 girls and 15 boys. The mean age at the onset of the disease was 7.6 & PLUSMN;3.6 years. The median duration of follow-up was 35 (6-144) months. Twenty-nine patients (60.4%) had monocyclic, 7 (14.6%) patients had polycyclic, and 12 (25%) patients had chronic persistent disease course. At the time of enrollment, 35 (72.9%) patients were in remission, while 13 (27.1%) patients had active disease. Calcinosis developed in 11 patients (22.9%). Children having myalgia, livedo racemosa, skin hypopigmentation, lower alanine aminotransferase (ALT) levels, and higher physician visual analog scores at the time of diagnosis had a higher risk for calcinosis. Calcinosis was also more common in children with diagnostic delay and chronic persistent disease course. None of these parameters remained independent risk factors for calcinosis in multivariate logistic regression analysis. CONCLUSION: The rate of mortality has decreased dramatically over decades in JDM, but the rate of calcinosis has not changed proportionately. Long duration of active, untreated disease is accepted as the main risk factor for calcinosis. We have seen that calcinosis was more common in children having myalgia, livedo racemosa, skin hypopigmentation, lower ALT levels, and higher physician visual analog scores at the time of diagnosis.Keywords
This publication has 31 references indexed in Scilit:
- Incidence and prevalence of inflammatory myopathies: a systematic reviewRheumatology, 2014
- Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onsetRheumatology, 2014
- Clinical features and disease course of patients with juvenile dermatomyositisInternational Journal of Rheumatic Diseases, 2013
- The PRINTO criteria for clinically inactive disease in juvenile dermatomyositisAnnals of the Rheumatic Diseases, 2013
- The Clinical Phenotypes of the Juvenile Idiopathic Inflammatory MyopathiesMedicine, 2013
- Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23 years of a single center’s experiencePediatric Rheumatology, 2012
- Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up studyScandinavian Journal of Rheumatology, 2011
- Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatmentArthritis & Rheumatism, 2009
- Long-term outcomes in juvenile dermatomyositis: How did we get here and where are we going?Current Rheumatology Reports, 2005
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975